Journal of Clinical Pediatrics ›› 2022, Vol. 40 ›› Issue (12): 899-904.doi: 10.12372/jcp.2022.22e0410
• Urinary System Disease • Previous Articles Next Articles
WANG Ren, XIA Zhengkun, ZHANG Pei, GAO Chunlin(
)
Received:2022-03-23
Published:2022-12-15
Online:2022-12-06
Contact:
GAO Chunlin
E-mail:shuangmu34@163.com
WANG Ren, XIA Zhengkun, ZHANG Pei, GAO Chunlin. Clinical and prognostic significance of glomerular C3 deposition in children with primary membranous nephropathy[J].Journal of Clinical Pediatrics, 2022, 40(12): 899-904.
"
| 项 目 | LI组(n=92) | HI组(n=121) | 统计量 | P |
|---|---|---|---|---|
| 年龄[M(P25~P75)]/岁 | 15.0(12.3~16.0) | 16.0(14.0~17.0) | Z=3.23 | 0.001 |
| 男性[n(%)] | 47(51.1) | 72(59.5) | χ2=1.50 | 0.220 |
| 收缩压[M(P25~P75)]/mmHg | 120.0(110.0~126.0) | 120.0(110.0~130.0) | Z=0.43 | 0.667 |
| 舒张压[M(P25~P75)]/mmHg | 74.0(68.0~80.0) | 73.0(70.0~80.0) | Z=0.28 | 0.783 |
| 24 h尿蛋白定量[M(P25~P75)]/g·L-1 | 1.7(0.9~2.8) | 3.2(1.8~6.3) | Z=4.73 | <0.001 |
| 血尿[n(%)] | 54(58.7) | 90(74.4) | χ2=5.87 | 0.015 |
| 蛋白尿严重程度[n(%)] | χ2=14.10 | <0.001 | ||
| 大量蛋白尿 | 42(45.7) | 86(71.1) | ||
| 非大量蛋白尿 | 50(54.3) | 35(28.9) | ||
| 血清白蛋白(x±s)/g·L-1 | 34.4±7.7 | 28.4±6.1 | t=4.70 | <0.001 |
| eGFR/ mL·min-1·1.73 m-2 | 166.0(141.7~198.3) | 149.9(137.7~181.0) | Z=2.35 | 0.019 |
| 病理分期[n(%)] | χ2=1.07 | 0.785 | ||
| Ⅰ期 | 25(27.2) | 27(22.3) | ||
| Ⅱ期 | 38(41.3) | 58(47.9) | ||
| Ⅲ期 | 25(27.2) | 31(25.6) | ||
| IV期 | 4(4.3) | 5(4.1) | ||
| IgG染色强度[n(%)] | χ2=4.17 | 0.041 | ||
| ++ | 88(95.7) | 106(87.6) | ||
| +++ | 4(4.3) | 15(12.4) | ||
| IFTA分级[n(%)] | χ2=2.53 | 0.282 | ||
| 轻度 | 80(87.0) | 97(80.2) | ||
| 中度 | 1(1.1) | 5(4.1) | ||
| 重度 | 11(12.0) | 19(15.7) |
"
| 项 目 | LI组(n=92) | HI组(n=121) | 统计量 | P |
|---|---|---|---|---|
| 随访时间[M(P25~P75)]/月 | 43.0(13.0~85.0) | 57.0(20.0~86.0) | Z=1.16 | 0.248 |
| 末次随访eGFR[M(P25~P75)]/mL·min-1·1.73 m-2 | 138.1(131.0~147.0) | 135.0(122.6~149.8) | Z=1.84 | 0.066 |
| 末次随访24h尿蛋白[M(P25~P75)]/g·L-1 | 0.4(0.3~2.1) | 0.6(0.3~3.1) | Z=1.18 | 0.237 |
| 治疗方案[n(%)] | ||||
| 他克莫司 | 35(38.0) | 47(38.8) | χ2=0.01 | 0.905 |
| 环磷酰胺 | 13(14.1) | 5(4.1) | χ2=6.75 | 0.009 |
| 吗替麦考酚酯 | 13(14.1) | 24(19.8) | χ2=1.19 | 0.276 |
| 利妥昔单抗 | 5(5.4) | 10(8.3) | χ2=0.64 | 0.424 |
| 保守治疗 | 32(34.8) | 42(34.7) | χ2=0.00 | 0.991 |
| 进展至ESRD(n) | 1(1.1) | 5(4.1) | χ2=0.83 | 0.362 |
| 转归[n(%)] | χ2=2.30 | 0.317 | ||
| CR | 29(31.5) | 27(22.3) | ||
| PR | 39(42.4) | 59(48.8) | ||
| NR | 24(26.1) | 35(28.9) |
"
| 因 素 | 达ESRD时间(M±SE) | χ2值 | P | |
|---|---|---|---|---|
| 性别 | 男 | 57.0±5.8 | 2.78 | 0.095 |
| 女 | 44.0±6.3 | |||
| 发病年龄 | ≤13岁 | 41.0±5.6 | 1.46 | 0.228 |
| >13岁 | 58.7±6.1 | |||
| 血白蛋白 | ≤25 g·L-1 | 43.3±6.0 | 2.12 | 0.145 |
| >25 g·L-1 | 57.8±7.4 | |||
| 基线eGFR | ≤90 mL·min-1·1.73 m-2 | 13.0±2.1 | 165.00 | <0.001 |
| >90 mL·min-1·1.73 m-2 | 55.1±7.9 | |||
| IgG染色强度 | ++ | 54.9±7.4 | 0.21 | 0.644 |
| +++ | 46.4±5.6 | |||
| C3染色强度 | <++ | 49.9±7.9 | 0.77 | 0.381 |
| ≥++ | 57.5±4.3 | |||
| 病理分期 | Ⅰ期 | 42.1±4.3 | 0.78 | 0.421 |
| Ⅱ期 | 56.3±5.5 | |||
| Ⅲ期 | 59.7±7.7 | |||
| IV期 | 58.3±8.3 | |||
| 24 h尿蛋白定量 | <50 mg·kg-1 | 50.0±6.4 | 0.80 | 0.371 |
| ≥50 mg·kg-1 | 55.2±7.9 | |||
| [1] |
Liu J, Zha Y, Zhang P, et al. The association between serum complement 4 and kidney disease progression in idiopathic membranous nephropathy: a multicenter retrospective cohort study[J]. Front Immunol, 2022, 13: 896654.
doi: 10.3389/fimmu.2022.896654 |
| [2] |
Wang YN, Feng HY, Nie X, et al. Recent advances in clinical diagnosis and pharmacotherapy options of membranous nephropathy[J]. Front Pharmacol, 2022, 13: 907108.
doi: 10.3389/fphar.2022.907108 |
| [3] | 中华医学会儿科学分会肾脏学组. 儿童激素敏感、复发/依赖肾病综合征诊治循证指南(2016)[J]. 中华儿科杂志, 2017, 55(10): 729-734. |
| [4] | 王忍. 儿童原发性膜性肾病研究进展[J]. 临床儿科杂志, 2021, 39(7): 549-552. |
| [5] |
Alsharhan L, Beck LJ. Membranous nephropathy: core curriculum 2021[J]. Am J Kidney Dis, 2021, 77(3): 440-453.
doi: 10.1053/j.ajkd.2020.10.009 pmid: 33487481 |
| [6] |
Oto OA, Demir E, Mirioglu S, et al. Clinical significance of glomerular C3 deposition in primary membranous nephropathy[J]. J Nephrol, 2021, 34(2): 581-587.
doi: 10.1007/s40620-020-00915-w pmid: 33387338 |
| [7] | 王楠楠. 儿童特发性膜性肾病诊疗进展[J]. 临床儿科杂志, 2021, 39(6): 476-480. |
| [8] |
Fervenza FC, Glassock RJ. Molecular characterization of membranous nephropathy: quo vadis?[J]. J Am Soc Nephrol, 2022, 33(6): 1057-1059.
doi: 10.1681/ASN.2022040395 pmid: 35577559 |
| [9] |
Teisseyre M, Cremoni M, Boyer-Suavet S, et al. Advances in the management of primary membranous nephropathy and rituximab-refractory membranous nephropathy[J]. Front Immunol, 2022, 13: 859419.
doi: 10.3389/fimmu.2022.859419 |
| [10] |
Horvatic I, Ljubanovic DG, Bulimbasic S, et al. Prognostic significance of glomerular and tubulointerstitial morphometry in idiopathic membranous nephropathy[J]. Pathol Res Pract, 2012, 208(11): 662-667.
doi: 10.1016/j.prp.2012.08.004 pmid: 22995635 |
| [11] |
Chinello C, de Haan N, Capitoli G, et al. Definition of IgG subclass-specific glycopatterns in idiopathic membranous nephropathy: aberrant IgG glycoforms in blood[J]. Int J Mol Sci, 2022, 23(9): 4664.
doi: 10.3390/ijms23094664 |
| [12] |
Tsuboi N, Kawamura T, Miyazaki Y, et al. Low glomerular density is a risk factor for progression in idiopathic membranous nephropathy[J]. Nephrol Dial Transplant, 2011, 26: 3555-3560.
doi: 10.1093/ndt/gfr399 |
| [13] |
Ponticelli C, Patrizia P, Del Vecchio L, et al. The evolution of the therapeutic approach to membranous nephropathy[J]. Nephrol Dial Transplant, 2021, 36: 768-773.
doi: 10.1093/ndt/gfaa014 |
| [14] |
Yoshimoto K, Yokoyama H, Wada T, et al. Pathologic findings of initial biopsies reflect the outcomes of membranous nephropathy[J]. Kidney Int, 2004, 65(1): 148-153.
pmid: 14675045 |
| [15] |
Cattran D. Management of membranous nephropathy: when and what for treatment[J]. J Am Soc Nephrol, 2005, 16(5): 1188-1194.
pmid: 15800117 |
| [16] |
Sprangers B, Bomback AS, Cohen SD, et al. Idiopathic membranous nephropathy: clinical and histologic prognostic features and treatment patterns over time at a tertiary referral center[J]. Am J Nephrol, 2012, 36(1): 78-89.
doi: 10.1159/000339628 pmid: 22739228 |
| [17] |
Spranger J, Homberg A, Sonnberger M, et al. Reporting guidelines for Delphi techniques in health sciences: a methodological review[J]. Z Evid Fortbild Qual Gesundhwes, 2022, 172: 1-11.
doi: 10.1016/j.zefq.2022.04.025 pmid: 35718726 |
| [1] | LIN Jinfeng, CHEN Yi, DENG Yan, FENG Ai, HUANG Juan, CHEN Lizhu, XIE Jingqi, NIE Xiaojing. A comparative study on the detection of anti-Nephrin antibodies in children's nephrotic syndrome by chemiluminescence method and cell-based assay [J]. Journal of Clinical Pediatrics, 2026, 44(8): 682-689. |
| [2] | ZHENG Fangyuan, WANG Miao, DING Mingming, LU Aidong, JIA Yueping, ZENG Huimin, ZHANG Leping. Next-generation sequencing identified gene variants and their prognostic impact in pediatric Philadelphia chromosome positive acute lymphoblastic leukemia [J]. Journal of Clinical Pediatrics, 2026, 44(8): 690-697. |
| [3] | ZHANG Xiao, FANG Hongjun, KUANG Xiaojun, WANG Lijuan, WU Zhao, JIANG Sha, LI Pei, WU Liwen. Analysis of the clinical and electrophysiological characteristics of atonic seizures in children [J]. Journal of Clinical Pediatrics, 2026, 44(8): 698-704. |
| [4] | WANG Mengqian, YANG Hui. Case series analysis of 13 intestinal Behcet’s syndrome in children [J]. Journal of Clinical Pediatrics, 2026, 44(8): 705-711. |
| [5] | WU Xirong, GAO Qi, GUO Siyuan, YIN Qingqin, QIN Qiang, YIN Ju, JIAO Anxia, CHEN Chenghao, WU Di, WANG Bei, DUAN Xiaomin, PENG Yun, XU Baoping, GAO Liwei. Clinical characteristics and prognosis of pulmonary mucormycosis in children with diabetes mellitus [J]. Journal of Clinical Pediatrics, 2026, 44(8): 712-720. |
| [6] | HAN Yanan, GE Lanlan, CUI Jieyuan. A case report of branchio-oto-renal syndrome caused by EYA1 gene variant with a 6-year follow-up [J]. Journal of Clinical Pediatrics, 2026, 44(8): 721-726. |
| [7] | SHI Jiayi, GAO Chunlin, JIA Lili, LU Yunyun, SUN Tao, ZHU Xiaodong, XIA Zhengkun, ZHANG Pei. Phenotypic characteristics and prognostic analysis of a pedigree with childhood isolated nephrotic syndrome caused by compound heterozygous mutations in the COQ2 gene [J]. Journal of Clinical Pediatrics, 2026, 44(8): 727-732. |
| [8] | Rachel Rosen, Osvaldo Borrelli, Christophe Faure, Katja Karrento, Usha Krishnan, Samuel Nurko, Nathalie Rommel, Alan Silverman, Michiel van Wijk, Marc Benninga (Author), Chinese Medical Association Parenteral and Enteral Nutrition Branch Pediatrics Group, The Subspecialty Group of Gastroenterology, The Society of Pediatric, Chinese Medical Association, Gastroenterology Group, Pediatrician Branch, Chinese Medical Doctor Association (Translator). Core interpretation and explanation of Rome Ⅴ diagnostic criteria: upper gastrointestinal disorders of gut-brain interaction in children and adolescents [J]. Journal of Clinical Pediatrics, 2026, 44(7): 595-608. |
| [9] | Carlo Di Lorenzo, Miguel Saps, Bruno P. Chumpitazi, Shaman Rajindrajith, Annamaria Staiano, Nikhil Thapar, Miranda van Tilburg, Carlos Velasco-Benítez, Arine Vlieger (Author), Chinese Medical Association Parenteral and Enteral Nutrition Branch Pediatrics Group, The Subspecialty Group of Gastroenterology, The Society of Pediatric, Chinese Medical Association, Gastroenterology Group, Pediatrician Branch, Chinese Medical Doctor Association (Translator). Core interpretation and explanation of Rome Ⅴ diagnostic criteria: lower and biliary disorders of gut-brain interaction in children and adolescents [J]. Journal of Clinical Pediatrics, 2026, 44(7): 609-621. |
| [10] | LI Xufeng, TANG Haoxun, LI Xingjun, ZHANG Lize, GAO Chenqing, ZHAO Shunying, LIU Jianhua. Clinical characteristics, chest CT imaging phenotypes, and their correlation with prognosis in 76 children with Chlamydia pneumoniae pneumonia [J]. Journal of Clinical Pediatrics, 2026, 44(7): 622-627. |
| [11] | WANG Zhen, SHAO Jingbo, ZHANG Na, XIA Min, ZHU Jiashi, DU Chengkan, LI Hong. Factors influencing long-term recurrence in pediatric acute lymphoblastic leukemia patients with low-risk disease at initial diagnosis: a five-year follow-up analysis of 254 cases from a single center [J]. Journal of Clinical Pediatrics, 2026, 44(7): 628-635. |
| [12] | GUO Xuemei, XUE Yao, WANG Yongren, RONG Liucheng, FANG Yongjun, LIN Rufeng. Clinical features and prognosis of childhood acute myeloid leukemia with CBFA2T3::GLIS2 fusion [J]. Journal of Clinical Pediatrics, 2026, 44(7): 636-643. |
| [13] | YANG Lijun, FU Dongxia, CUI Yan, YANG Junmei, ZHANG Liming. Clinical manifestation and genetic analysis of CHARGE syndrome caused by CHD7 gene variation [J]. Journal of Clinical Pediatrics, 2026, 44(7): 644-650. |
| [14] | HU Yan, YANG Fan, LIANG Aimin, MAO Meng. Identification and management of faltering growth in children: insights from the 13th International Conference on Nutrition and Growth [J]. Journal of Clinical Pediatrics, 2026, 44(6): 485-488. |
| [15] | LIU Ziyao, WANG Congying, WANG Hongmao, ZHANG Mingming, XU Yingjie, LAI Jianming, NIU Wenquan, LI Xiaohui. Early differentiation of Kawasaki disease with joint symptoms and systemic juvenile idiopathic arthritis with Kawasaki disease-like symptoms: a single-center retrospective study [J]. Journal of Clinical Pediatrics, 2026, 44(6): 489-498. |
|
||